SteadyMed
SteadyMed develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension.
Business Model:
Revenue: $1.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed SteadyMed Information
SteadyMed was acquired by
United Therapeutics.
The acquisition happend on 2018-04-30.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 2603 Camino Ramon
City: San Ramon
State: CA
Zip: 94583
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$5M
Raised Total:$114M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
SteadyMed develops and commercializes drug product candidates for the subcutaneous treatment of pulmonary arterial hypertension.
Contact Phone:
+19252724999
Contact Email:
SteadyMed went public on 3/20/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/20/2015
IPO Valuation:
$160M
Ticker Symbol:
STDY
IPO Price:
$8.5/share
Amount Raised:
$40M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
